Skip to main content
GHRS logo

GH Research PLC

GHRSNASDAQHealthcareBiotechnology

$19.18Today:- (-)1Y +39.41%

As of Oct 26, 2026 close

Market cap
$1.28B
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$12.04$31.44
Volume (live)
-
Avg. volume (3M)
325.50K

GH Research (GHRS) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), GH Research reported total assets of $288.23M and total liabilities of $8.53M. Shareholders' equity was $279.70M, up 56.3% from $178.95M a year earlier. Total debt stood at $512.00K against $280.71M in cash and short-term investments, a net cash position of $280.20M. That puts debt-to-equity at 0.00, compared with 0.00 a year earlier.

GH Research Balance Sheet Analysis

Values in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for GH Research PLC (GHRS) - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Period endingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019
Current Assets
Cash and Cash Equivalents246.25100.7978.42165.96276.785.900.50
Short-Term Investments34.4648.5383.140.000.000.000.00
Cash & Short-Term Investments280.71149.32161.56165.96276.785.900.50
Accounts Receivable1.301.730.300.090.050.010.00
Inventory0.000.000.000.003.010.000.00
Other Current Assets5.273.172.232.593.070.010.01
Total Current Assets285.98154.23164.09168.54279.845.910.50
Non-Current Assets
Property, Plant & Equipment (Net)0.620.751.070.100.080.000.00
Long-Term Investments0.0033.3061.1485.720.000.000.00
Other Non-Current Assets1.630.000.000.000.000.000.00
Total Non-Current Assets2.2534.0562.2185.820.080.000.00
Total Assets288.23188.27226.30254.36279.925.910.50
Current Liabilities
Accounts Payable3.773.743.491.870.880.000.09
Short-Term Debt0.370.260.340.000.000.000.00
Accrued Liabilities3.343.872.332.581.790.25-
Other Current Liabilities4.244.962.872.681.870.250.01
Total Current Liabilities8.388.956.704.552.750.250.10
Non-Current Liabilities
Long-Term Debt0.150.370.630.000.000.000.00
Other Non-Current Liabilities0.000.000.000.000.000.000.00
Total Non-Current Liabilities0.150.370.630.000.000.000.00
Total Liabilities8.539.327.334.552.750.250.10
Stockholders' Equity
Common Stock1.551.301.301.301.300.870.80
Retained Earnings-154.43-106.45-67.94-32.49-10.04-0.84-0.39
Accumulated Other Comprehensive Income1.52-7.37-5.86-23.40-18.500.20-0.01
Additional Paid-in Capital431.06291.46291.46291.45291.455.430.00
Shares Outstanding62.0352.0352.0352.0252.02--
Total Stockholders' Equity279.70178.95218.97249.82277.185.670.40
Total Liabilities & Equity288.23188.27226.30254.36279.925.910.50

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About GH Research Balance Sheet

How much debt does GH Research have?

GH Research had total debt of $512.00K as of Dec 31, 2025, against $280.71M in cash and short-term investments. Its debt-to-equity ratio was 0.00. Total debt was $624.00K a year earlier.

What are GH Research's total assets?

GH Research reported total assets of $288.23M as of Dec 31, 2025, up 53.1% from $188.27M a year earlier. Total liabilities were $8.53M.

What is GH Research's shareholders' equity?

GH Research's shareholders' equity was $279.70M as of Dec 31, 2025, or about $4.51 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition